New research article in The Lancet Infectious Diseases>
#Ganaplacide (KAF156) plus #lumefantrine solid dispersion formulation combination for uncomplicated #Plasmodium #falciparum #malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00209-8/fulltext
#malaria #falciparum #plasmodium #lumefantrine #ganaplacide
New research article in The Lancet Microbe>
Association between domesticated animal ownership and #Plasmodium #falciparum parasite prevalence in the Democratic Republic of the Congo: a national cross-sectional study
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00109-X/fulltext
#malaria #falciparum #plasmodium
On the worsening #AntiMalarial #DrugResistance in #Africa
#malaria #drugs #artemisinin #PlasmodiumFalciparum #Plasmodium #falciparum #protozoa #Anopheles #mosquito
https://www.dw.com/en/africa-antimalarial-drug-resistance-on-the-rise/a-64306141
#antimalarial #drugresistance #africa #malaria #drugs #artemisinin #plasmodiumfalciparum #plasmodium #falciparum #protozoa #anopheles #mosquito
New #research paper led by Georgia Gore-Langton at #LSHTM in collaboration with Andrew Tatem, Natalia Tejedor-Garavito and Adelle Wigley at WorldPop - Global estimates of pregnancies at risk of Plasmodium #falciparum and Plasmodium #vivax infection in 2020 and changes in risk patterns since 2000 - in #PLOSGPH #malaria #maternalhealth #MalariaAtlas https://doi.org/10.1371/journal.pgph.0001061
#research #LSHTM #falciparum #vivax #PLOSGPH #malaria #maternalhealth #MalariaAtlas